Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
PHASE3
The primary objective of this study is to evaluate the non-inferiority of s...
Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA⢠in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
PHASE3
The purpose of this study is to compare the antiretroviral activity of dora...
Effects of Switching From ATRIPLA⢠(Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)
PHASE2
This study aims to evaluate a switch from fixed dose combination (FDC) trea...
Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
PHASE3
To evaluate the safety and efficacy of StribildĀ®, a single tablet regimen (...
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
PHASE2
The objective of this double-blinded, multicenter, randomized, active-contr...